153 related articles for article (PubMed ID: 26700872)
1. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
Jain P; Verstovsek S; Wang W; Loghavi S; Torres HA; Estrov Z; Patel KP; Pemmaraju N
Leuk Lymphoma; 2016 Aug; 57(8):1969-73. PubMed ID: 26700872
[No Abstract] [Full Text] [Related]
2. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera.
Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Camacho L; Fernández-Rodríguez C; Pairet S; Longarón R; Ancochea Á; Senín A; Florensa L; Besses C
Eur J Haematol; 2015 Mar; 94(3):251-7. PubMed ID: 25082530
[TBL] [Abstract][Full Text] [Related]
4. Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera.
Swierczek SI; Yoon D; Bellanné-Chantelot C; Kim SJ; Saint-Martin C; Delhommeau F; Najman A; Prchal JT
Haematologica; 2011 May; 96(5):775-8. PubMed ID: 21273266
[TBL] [Abstract][Full Text] [Related]
5. ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
Andréasson B; Pettersson H; Wasslavik C; Johansson P; Palmqvist L; Asp J
Br J Haematol; 2020 Jun; 189(5):913-919. PubMed ID: 32066200
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
Vainchenker W; Kralovics R
Blood; 2017 Feb; 129(6):667-679. PubMed ID: 28028029
[TBL] [Abstract][Full Text] [Related]
7. JAK2V⁶¹⁷F/TET2 mutations: does the order matter?
Pronier E; Quivoron C; Bernard OA; Villeval JL
Haematologica; 2011 May; 96(5):638-40. PubMed ID: 21531945
[No Abstract] [Full Text] [Related]
8. Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Brecqueville M; Rey J; Bertucci F; Coppin E; Finetti P; Carbuccia N; Cervera N; Gelsi-Boyer V; Arnoulet C; Gisserot O; Verrot D; Slama B; Vey N; Mozziconacci MJ; Birnbaum D; Murati A
Genes Chromosomes Cancer; 2012 Aug; 51(8):743-55. PubMed ID: 22489043
[TBL] [Abstract][Full Text] [Related]
9. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
10. Competing cell clones in myeloproliferative neoplasm.
Al-Kali A; Verstovsek S; Kantarjian H; Luthra R; Cortes J
Blood; 2010 Dec; 116(23):5074-5. PubMed ID: 21127188
[No Abstract] [Full Text] [Related]
11. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
Portell CA; Sekeres MA; Rogers HJ; Tiu RV
Br J Haematol; 2012 Apr; 157(2):266-7. PubMed ID: 22150289
[No Abstract] [Full Text] [Related]
12. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
[TBL] [Abstract][Full Text] [Related]
13. Seven Co-Occurring Mutations in a Patient with Acute Myeloid Leukemia Identified by Next-Generation Sequencing.
Lee JH; Lee JH
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232041
[TBL] [Abstract][Full Text] [Related]
14. Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
Alvarez-Larrán A; Senín A; Fernández-Rodríguez C; Pereira A; Arellano-Rodrigo E; Gómez M; Ferrer-Marin F; Martínez-López J; Camacho L; Colomer D; Angona A; Navarro B; Cervantes F; Besses C; Bellosillo B; Hernández-Boluda JC
Br J Haematol; 2017 Sep; 178(5):764-771. PubMed ID: 28542718
[TBL] [Abstract][Full Text] [Related]
15. DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.
Segura-Díaz A; Stuckey R; Florido Y; Sobas M; Álvarez-Larrán A; Ferrer-Marín F; Pérez-Encinas M; Carreño-Tarragona G; Fox ML; Tazón Vega B; Cuevas B; López Rodríguez JF; Sánchez-Farías N; González-Martín JM; Gómez-Casares MT; Bilbao-Sieyro C;
Thromb Haemost; 2024 Jul; 124(7):669-675. PubMed ID: 38190984
[TBL] [Abstract][Full Text] [Related]
16. Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.
Chan SM; Majeti R
Int J Hematol; 2013 Dec; 98(6):648-57. PubMed ID: 23949914
[TBL] [Abstract][Full Text] [Related]
17. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia.
Jelinek J; Oki Y; Gharibyan V; Bueso-Ramos C; Prchal JT; Verstovsek S; Beran M; Estey E; Kantarjian HM; Issa JP
Blood; 2005 Nov; 106(10):3370-3. PubMed ID: 16037387
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and gene mutation status of polycythemia vera and essential thrombocythemia in Japan].
Dan K; Yamaguchi H
Rinsho Ketsueki; 2010 Jul; 51(7):508-14. PubMed ID: 20693770
[No Abstract] [Full Text] [Related]
19. Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient.
Rao N; Butcher CM; Lewis ID; Ross DM; Melo JV; Scott HS; Bardy PG; D'Andrea RJ
Br J Haematol; 2012 Jan; 156(2):268-70. PubMed ID: 21859430
[No Abstract] [Full Text] [Related]
20. Lineage restriction analyses in CHIP indicate myeloid bias for
Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
